Akums Drugs and Pharmaceuticals (NSE:AKUMS) EPS (Basic) : ₹18.39 (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Akums Drugs and Pharmaceuticals EPS (Basic)?

Akums Drugs and Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₹9.76. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹18.39.

Akums Drugs and Pharmaceuticals's EPS (Diluted) for the three months ended in Mar. 2025 was ₹9.76. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹18.39.

Akums Drugs and Pharmaceuticals's EPS without NRI for the three months ended in Mar. 2025 was ₹9.41. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 17.63.

During the past 12 months, Akums Drugs and Pharmaceuticals's average EPS without NRIGrowth Rate was 24.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 51.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Akums Drugs and Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 51.30% per year. The lowest was 13.90% per year. And the median was 32.60% per year.

Akums Drugs and Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Akums Drugs and Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akums Drugs and Pharmaceuticals EPS (Basic) Chart

Akums Drugs and Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

EPS (Basic)

7.80

-15.94

6.22

0.05

22.60

Akums Drugs and Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial				12.31	-2.32	4.37	4.26	9.76

Akums Drugs and Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Akums Drugs and Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(3437.77	-	0)	/	152.114
	=	22.60

Akums Drugs and Pharmaceuticals's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1532.18	-	0)	/	163.224
	=	9.39

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹18.39

Akums Drugs and Pharmaceuticals (NSE:AKUMS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Akums Drugs and Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Akums Drugs and Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akums Drugs and Pharmaceuticals Ltd (NSE:AKUMS) » Definitions » EPS (Basic)

Traded in Other Exchanges

544222:India

Address

Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083

Website

https://www.akums.in

Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Akums Drugs and Pharmaceuticals Headlines

No Headlines